United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-006_277200d5-a863-4411-8c1b-aac8d7fde6a6
- Product NDC
- 68382-006
- Form
- TABLET
- Composition / generic term
- Lamotrigine
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090127
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMOTRIGINE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-006-01) · 68382-006-01
- 500 TABLET in 1 BOTTLE (68382-006-05) · 68382-006-05
- 1000 TABLET in 1 BOTTLE (68382-006-10) · 68382-006-10
- 25 TABLET in 1 BOTTLE (68382-006-11) · 68382-006-11
- 90 TABLET in 1 BOTTLE (68382-006-16) · 68382-006-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →